Med Aditus Pharmaceuticals, Inc. uniquely combines continuous modular manufacturing technology with blockchain-powered digital quality management system to redefine pharmaceutical production. Our first-in-Africa, this innovative technology will accelerate production, decrease costs, and effectively respond to the changing market needs of the region.
The state-of-the-art continuous modular manufacturing production line, with built-in real-time process controls and product release, can produce high-quality pharmaceutical products at lower costs, achieve maximum production flexibility, and can be rapidly scaled to accelerate the domestic drug manufacturing capacity of Africa.
We will leverage blockchain technology to ensure integrity and transparency of cGMP manufacturing operations, to develop an efficient and tamper-proof supply chain, and create a patient-reported trustworthy medication adherence and health outcomes database. Our real-time permissioned data sharing will lead to groundbreaking regulatory innovation.
Our secure data platform delivers insights into medication adherence and critical health outcome data, empowering us and others to shape effective public health policies, and develop accessible treatments for pressing health issues in the region.
We are committed to producing medicines for the most needed health issues of the region caused by the steady increase of non-communicable diseases (NCDs) with particular focus on diabetes, cardiovascular diseases, and cancer. We are also committed to addressing the problem of inadequate access to quality pediatric formulations, a major unmet need of this most vulnerable population.
© Med Aditus Pharmaceuticals 2024
